Ignite Creation Date:
2025-12-24 @ 5:20 PM
Ignite Modification Date:
2026-01-02 @ 10:20 PM
Study NCT ID:
NCT00056550
Status:
COMPLETED
Last Update Posted:
2012-10-16
First Post:
2003-03-17
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Assess Incidence of Deep Vein Thrombosis(DVT)Following Administration of Recombinant Human Antithrombin (rhAT) to Hereditary Antithrombin(AT) Deficient Patients in High Risk Situations.
Sponsor:
rEVO Biologics
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
GTC AT III 01002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None